Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"DNMTi"”.
-
Harnessing epigenetic regulation to improve cancer therapy
… combination of DNA methyltransferase inhibitors (DNMTi) for their potential to increase the murine MAGE-type antigen P1A expression. We show that DNMTis upregulate P1A expression at the transcriptional and protein levels, and increase and enhance MHC-class I presentation in vitro. DNMTi …
-
Molecular response factors of demethylating therapy in AML
… towards the DNA methyltransferase inhibitor (DNMTi) treatment, we conducted a pooled short hairpin RNA (shRNA)-based screen in three human leukemia cell lines using an inducible custom shRNA library targeting more than 660 different genes involved in epigenetic pathways. After selection of …
-
IMPROVING MANAGEMENT OF NON-SMALL CELL LUNG CANCER BY TARGETING THE STAT3 PATHWAY IN COMBINATION WITH EPIGENETIC THERAPY
… combinatorial DNA methyltransferase inhibition (DNMTi) paired with histone deacetylase inhibition (HDACi). However, durable responses from the application of epigenetic therapy alone or in combination with other therapies have remained elusive in NSCLC, potentially because of continued …
-
Glioma genetic profiling: The role of DNA repair and telomerase
… therapeutic agent. To address these issues three DNMTI (methylation gene) siRNAs were used, downregulating DNMTI directly and hTERT indirectly (possibly via the promoter methylation inhibition mechanism). Combining siRNA and chemotherapeutic agents (TMZ or taxol) enhanced the effects of both the …
-
EPIGENETIC THERAPY TIES MYC DEPLETION TO REVERSING IMMUNE EVASION AND TREATING LUNG CANCER
Combining DNA demethylating agents (DNMTis) with histone deacetylase inhibitors (HDACis) holds promise for enhancing cancer immune therapy. Herein, pharmacologic and isoform specificity of HDACi’s are investigated to guide their addition to a DNMTi, thus devising a new, low-dose, sequential regimen …
-
Functional genetic characterization of acute myeloid leukemia using demethylating agents, RNA interference and genome editing technologies
… mit diesen DNA-Methyltransferase-Inhibitoren (DNMTis) ist, dass nach einem initialem Ansprechen der Therapie die Patienten häufig ungeklärterweise eine Resistenz entwickeln.<br>Zum Aufdecken dieser Resistenzmechansimen haben wir eine shRNA Library von 2668 shRNAs entwickelt, die gegen 668 an …
-
Difluoromethylornithine and 5-azacytidine promote tumor associated macrophages toward M1 polarization in an ovarian cancer mouse model.
… combines a DNA methyl transferase inhibitor (DNMTi) and an ornithine decarboxylase inhibitor that together, alter the tumor microenvironment to inhibit ovarian tumor growth. Previous work demonstrated that the DNMTi, 5-Azacytidine (AZA), activates type I interferon signaling to increase IFNγ+ …
-
AUGMENTING GUADECITABINE TO PROMOTE ANTICANCER IMMUNITY IN MURINE BREAST CANCER
… DNA methyl-transferase inhibitor (DNMTi). DNMTi’s have been shown to dysregulate the methylation state responsible for gene silencing, which leads to an upregulation of many silenced genes including cancer associated antigens. Guad was initially combined with intratumoral injections …
-
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth
… next-generation DNA methyltransferase inhibitor (DNMTi), we observed significantly reduced tumor burden in the 4T1 murine mammary carcinoma model. Guadecitabine treatment prevents excessive tumor-induced myeloid proliferation and systemic accumulation, and skews remaining MDSCs toward a beneficial …
-
Polyunsaturated Fatty Acids Alter the Epigenetic Landscape of Triple-Negative Breast Cancer (TNBC)
… deacetylase (HDACi) and DNA methyltransferases (DNMTi). Short chain fatty acids, have proven to be effective HDACi's, suggesting a possible role for other fats in epigenetic regulation. Research has shown that several omega-3 polyunsaturated fatty acids (PUFAs), specifically docosahexaenoic acid …
-
Anti-ovarian cancer effects of histone deacetylase inhibitors and calpain inhibitor
… (HDACi), and DNA methyl transferase I (DNMTI) inhibitors, in combination with other cytotoxic agents. HDACi are known to be effective against different types of leukemia’s, such as Cutaneous T-cell Lymphoma; however, they are not as effective against solid tumors when used as a single …
-
The role of epigenetic modifications in prostate tumourigenesis.
… if the DNA methyltransferase inhibitor (DNMTi) 5-aza-CdR was a potential treatment agent for prostate cancer, proliferation assays were performed in prostate cancer cells. A daily low-dose and prolonged 5-aza-CdR treatment regime was the most effective treatment in prostate cancer cells …
-
Synthetic approaches to the understanding of DNA nucleobase methylation
… tumor suppressor genes by DNMT inhibitors (DNMTi) is provides a relatively new approach to cancer therapy. A couple of irreversible nucleoside DNMT inhibitors have been developed clinically. However, due to their low specificity and high cellular toxicity, there is a clear need for the …
-
Understanding p53 Regulation on Transposable Elements in Cancer
… epigenetic therapy. Epigenetic therapy such as DNMTi and HDACi had passed clinical trials and been utilized in treating cancers. However the lack of their efficacy on other cancer types and certain patient populations remains puzzling. TEs are unleashed under epigenetic therapy due to the …